- Condition: Actinic Keratosis
Interventions: Drug: Ingenol mebutate gel, 0.015%; Drug: Vehicle gel
Sponsors: LEO Pharma; LEO Pharma
Recruiting - verified May 2012 - Condition: Branch Retinal Vein Occlusion
Interventions: Drug: Ranibizumab; Procedure: Laser
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified May 2012 - Condition: Colorectal Cancer
Interventions: Drug: bevacizumab [Avastin]; Drug: XELOX; Drug: bevacizumab [Avastin]; Drug: mFOLFOX6; Drug: bevacizumab [Avastin]; Drug: FOLFIRI
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Not yet recruiting - verified April 2012 - Condition: Acute GVH Disease
Intervention: Biological: Mesenchymal stromal cell therapy
Sponsors: Royal Perth Hospital; R.P.Herrmann; Royal Perth Hospital
Recruiting - verified April 2012 - Condition: Cardiovascular Disease
Interventions: Drug: N(t)RTI) + boosted protease inhibitors (PI/r); Drug: maraviroc + boosted protease inhibitors (PI/r); Drug: maraviroc + N(t)RTI)
Sponsors: Kirby Institute; Kirby Institute
Not yet recruiting - verified April 2012 - Condition: Psoriasis
Interventions: Drug: ASKP1240; Drug: Placebo
Sponsors: Astellas Pharma Inc; Astellas Pharma Global Development, Inc.; Kyowa Hakko Kirin Company, Limited
Recruiting - verified April 2012 - Condition: Melanoma
Interventions: Drug: dabrafenib plus trametinib; Drug: dabrafenib plus trametinib placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Not yet recruiting - verified May 2012 - Conditions: Guillain-Barré Syndrome; Miller Fisher Syndrome
Intervention:
Sponsors: Erasmus Medical Center; Erasmus Medical Center
Recruiting - verified May 2012 - Condition: Osteoarthritis
Interventions: Other: Hospital Inpatient Rehabilitation; Other: Hybrid Home Programme (HO)
Sponsors: South West Sydney Local Health District; Mark Buhagiar; HammondCare
Not yet recruiting - verified April 2012
 |
Paid Clinical Trials in Australia |
Clinical Trial Locations 